Explore Kincell Bio’s growing collection of articles, webinars, posters, videos, and more, featuring expert insights into the rapidly evolving cell therapy landscape.
Serial entrepreneur has created, built and sold three CDMOs GAINESVILLE, Fla. – May 21, 2024 – Kincell Bio, LLC (“Kincell”), a technology-forward...
Kincell Bio has acquired a state-of-the-art manufacturing facility in North Carolina, expanding our network to include late-phase and pivotal capabilities.
eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Kincell Bio, a contract development and manufacturing organization (CDMO) focused...
A small CDMO called Kincell Bio launched Wednesday, with its CEO hoping to fill a niche offering cell therapy manufacturing for early-stage...
Kincell Bio, a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies, today emerged from stealth with $36 million in...
Talk to an expert
Leveraging our science-first expertise and right-first-time quality, partner with Kincell Bio to advance your cell therapy from concept to commercialization.
"*" indicates required fields
